387 related articles for article (PubMed ID: 26067617)
1. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
3. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
5. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
6. Indirect Revascularization for Non-Moyamoya Disease Anterior Circulation Arterial Steno-occlusion: Clinical Features, Surgical Treatment, and Medium-Term Outcomes in Adults.
Tong H; Ma Y; Zhang Z; Mao Z; Yao B; Shang A; Liu R; Yu X; Zhou D
World Neurosurg; 2016 May; 89():293-300. PubMed ID: 26872520
[TBL] [Abstract][Full Text] [Related]
7. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
8. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
9. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
[TBL] [Abstract][Full Text] [Related]
10. Improvement in cerebral hemodynamic parameters and outcomes after superficial temporal artery-middle cerebral artery bypass in patients with severe stenoocclusive disease of the intracranial internal carotid or middle cerebral arteries.
Low SW; Teo K; Lwin S; Yeo LL; Paliwal PR; Ahmad A; Sinha AK; Teoh HL; Wong LY; Chong VF; Seet RC; Chan BP; Yeo TT; Chou N; Sharma VK
J Neurosurg; 2015 Sep; 123(3):662-9. PubMed ID: 26023999
[TBL] [Abstract][Full Text] [Related]
11. Direct versus indirect revascularization in the treatment of moyamoya disease.
Park SE; Kim JS; Park EK; Shim KW; Kim DS
J Neurosurg; 2018 Aug; 129(2):480-489. PubMed ID: 29076784
[TBL] [Abstract][Full Text] [Related]
12. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
13. Encephaloduroarteriosynangiosis (EDAS) revascularization for symptomatic intracranial atherosclerotic steno-occlusive (ERSIAS) Phase-II objective performance criterion trial.
Gonzalez NR; Jiang H; Lyden P; Song S; Schlick K; Dumitrascu O; Quintero-Consuegra MD; Toscano JF; Liebeskind DS; Restrepo L; Rao N; Hinman J; Alexander MJ; Schievink W; Piantadosi S; Saver JL
Int J Stroke; 2021 Aug; 16(6):701-709. PubMed ID: 33115382
[TBL] [Abstract][Full Text] [Related]
14. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
16. Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial.
Quintero-Consuegra MD; Toscano JF; Babadjouni R; Nisson P; Kayyali MN; Chang D; Almallouhi E; Saver JL; Gonzalez NR
Neurosurgery; 2021 Mar; 88(4):E312-E318. PubMed ID: 33469657
[TBL] [Abstract][Full Text] [Related]
17. Cerebral revascularization after the Carotid Occlusion Surgery Study: what candidates remain, and can we do better?
White TG; Abou-Al-Shaar H; Park J; Katz J; Langer DJ; Dehdashti AR
Neurosurg Focus; 2019 Feb; 46(2):E3. PubMed ID: 30717069
[TBL] [Abstract][Full Text] [Related]
18. Effect of revascularization on cognitive outcomes in intracranial steno-occlusive disease: a systematic review.
Kolb B; Fadel H; Rajah G; Saber H; Luqman A; Rangel-Castilla L
Neurosurg Focus; 2019 Feb; 46(2):E14. PubMed ID: 30717064
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia.
Bao XY; Zhang Y; Wang QN; Zhang Q; Wang H; Zhang ZS; Li DS; Duan L
World Neurosurg; 2018 Jul; 115():e482-e489. PubMed ID: 29684518
[TBL] [Abstract][Full Text] [Related]
20. The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease.
Komotar RJ; Starke RM; Otten ML; Merkow MB; Garrett MC; Marshall RS; Elkind MS; Connolly ES
J Neurosurg; 2009 May; 110(5):896-904. PubMed ID: 19199456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
